- Correspondence to Dr Tamas Shisha, Sandoz, a Novartis Division, Clinical Development, Industriestrasse 25, 83607 Holzkirchen, Germany;
- Received February 9, 2017
- Revised May 3, 2017
- Accepted May 4, 2017
- First published June 21, 2017.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.